pdsbiotech.com (PDSB) - שולי רווח גולמי ממכירות

The readiness of production capacities for the serial release of drugs determines the gross margin dynamics on the GURU.Markets chart, where the 0.00 level indicates the status of the parameter for PDS Biotechnology (PDSB). Success is based on the Versamune platform and a targeted approach to oncology. However, international cooperation and software patent protection remain vulnerable due to geopolitical risks affecting the conduct of overseas trials.
פילוחים אנליטיים ודוחות נתונים של חברת PDS Biotechnology Corp (PDSB)

PDS Biotechnology utilizes the Versamune platform to optimize costs in developing immunotherapies for various tumors, laying the foundation for high operational efficiency. Gross margin measures the portion of revenue minus direct production costs, allowing investors to use the gross profitability chart to filter out random expense spikes and assess the real scalability of the business without overpaying for overheated assets.